Aetna expands initiatives to simplify experiences for health care professionals and patients
CVSBundling medical procedures and pharmaceutical medications into one prior authorization Implementing end-to-end generative AI capabilities into Aetna Health app HARTFORD, Conn., Dec. 4, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announces key milestones in...
18 Million Aetna® Members Now Have Access to Innovative Program for Pelvic Health
CVS(NYSE:CVS) ASHCare™ Virtual Pelvic Health Program Allows Patients to Receive Best-of-Clinic Pelvic Health Physical Therapy from the Comfort of Home SAN DIEGO, Sept. 4, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company, recently partnered with American Specialty Health (ASH) to provide access to the...
Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic®
CVS(NYSE:CVS) CVS Health® survey finds more than 60 percent of consumers say they are likely to get a flu shot this season Enhanced flu testing and treatment offerings are also available in select CVS Pharmacy locations across 38 states WOONSOCKET, R.I., Sept. 3, 2025 /PRNewswire/ -- CVS Health® (NYSE:...
Pharmacy Benefits Manager Caremark Must Pay $290 Million After Trebled Damages and Assessed False Claims Act Penalties
CVSPHILADELPHIA, Aug. 21, 2025 /PRNewswire/ -- Berger Montague, a leading national plaintiffs' law firm, has won a $289,873,500 million final judgment on behalf of whistleblower, Sarah Behnke, in this False Claims Act whistleblower case against pharmacy benefits manager Caremark and related...
GiftCard Partners Announces the Addition of the CVS Select+™ Gift Card: Designed to Enhance Health and Wellness Initiatives
CVSNew CVS® gift card product supports everyday health and wellness with a restricted-spend gift card. WELLESLEY, Mass., Aug. 18, 2025 /PRNewswire-PRWeb/ -- GiftCard Partners, a leader in innovative gift card solutions, today announced the addition of the CVS Select+ Gift Card to the family...
Humana Backs Reforms To Limit Medicare Advantage Billing Practices
CVSHumana is joining lawmakers in support of limiting Medicare Advantage payments tied to home visit diagnoses.
What 10 Analyst Ratings Have To Say About CVS Health
CVSBarclays Maintains Overweight on CVS Health, Lowers Price Target to $79
CVSWhat Does the Market Think About CVS Health?
CVSPalantir: The Only Cathie Wood Pick Among S&P 500's Top Performers
CVSNRG Energy Inc leads S&P 500's 2024 leaderboard with 70% YTD gain. Palantir follows with 64% surge, only stock from Cathie Wood's ARK funds in top performers.
What the Options Market Tells Us About CVS Health
CVS8 Health Care Stocks With Whale Alerts In Today's Session
CVSBenzinga Market Summary: Tax Bill Clears The House, Solar Stocks Fall On Plans To Roll Back Clean Energy Credits, Centers For Medicare & Medicaid Services Announce Expansion Of Auditing Efforts For Medicare Advantage Plans
CVSHealth Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why
CVSHealth care stocks are tanking in Wednesday's extended trading after CMS announced a significant expansion of its auditing efforts for Medicare Advantage (MA) plans.
'CVS Bids For Rite Aid Stores, Patient Files in Pacific Northwest'- Bloomberg
CVSCVS Health Options Trading: A Deep Dive into Market Sentiment
CVSTruist Securities Maintains Buy on CVS Health, Raises Price Target to $84
CVSGlenview Capital Issues Statement On CVS Health; Highlights 25% Return On CVS Health Investment Since May 2024 As Turnaround Gains Traction, Citing Board Refresh, Cultural And Leadership Overhaul Under New CEO, Operational Gains, Deleveraging, Strategic B
CVSWells Fargo Maintains Overweight on CVS Health, Raises Price Target to $84
CVSRBC Capital Maintains Outperform on CVS Health, Raises Price Target to $81
CVSUBS Maintains Neutral on CVS Health, Raises Price Target to $71
CVSA Glimpse Into The Expert Outlook On CVS Health Through 10 Analysts
CVSWhy Is Novo Nordisk Stock Trading Higher On Friday?
CVSHealth Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease affecting patients with obesity.
Barclays Maintains Overweight on CVS Health, Raises Price Target to $82
CVSDOJ Says U.S. Alleges Aetna And Humana Each Conspired With Broker Defendants To Discriminate Against Medicare Beneficiaries With Disabilities; U.S Alleges Defendant Insurers Paid Hundreds Of Millions Of Dollars In Illegal Kickbacks To The Defendant Broker
CVSCVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
CVSWegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access initiatives.
CVS Health Partners With Wegovy Maker Novo Nordisk, Hikes 2025 Guidance
CVSCVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare performance.
Novo Nordisk Announced That CVS Caremark Has Decided That Wegovy (Semaglutide) Injection 2.4 Mg, The Most Widely Prescribed And Studied GLP-1 For Weight Loss, Will Soon Be The Preferred GLP-1 Medicine On Its Largest Commercial Template Formularies. This C
CVSCVS Health Lowers FY2025 GAAP EPS Guidance from $4.58-$4.83 to $4.23-$4.43 vs $4.37 Est
CVSCVS Health Raises FY2025 Adj EPS Guidance from $5.75-$6.00 to $6.00-$6.20 vs $5.91 Est
CVSCVS Health Q1 Adj. EPS $2.25 Beats $1.70 Estimate, Sales $94.59B Beat $93.64B Estimate
CVSDespite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook
CVSElevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street estimates.
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
CVSHealthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.
CVS, Humana and Elevance Shares Are Trading Lower Thursday: What's Going On?
CVSCVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.
Baird Maintains Neutral on CVS Health, Raises Price Target to $71
CVSTruist Securities Maintains Buy on CVS Health, Raises Price Target to $82
CVSWhat 8 Analyst Ratings Have To Say About CVS Health
CVSMizuho Maintains Outperform on CVS Health, Raises Price Target to $76
CVSBenzinga Market Summary: S&P Falls Below 5,000 Amid US-China Trade Tensions Ahead Of China Tariff Deadline, Chip Stocks Fall, Health Insurers Spike On Increased Payment Rates To Medicare Insurers
CVS3 Health Care Stocks Whale Activity In Today's Session
CVSBenzinga Market Summary: S&P Rebounds, 10-Year Rises, Health Insurers Spike On Increased Payment Rates To Medicare Insurers
CVSCVS Health Appoints Former UPS And Pepsi Exec As Finance Chief, Stock Soars
CVSCVS names Brian Newman CFO and Amy Compton-Phillips CMO as leadership shifts follow Q4 revenue growth and ongoing executive restructuring.
Bloomberg Reported Monday, CVS Health Is Facing Activist Investor
CVSCVS Expects Financial Results To Meet Or Exceed FY25 Guidance
CVSCVS Health Names Brian Newman As Executive Vice President And Chief Financial Officer Designate Effective April 21
CVSHealth Insurers Surge After Medicare Agency Increases Payment Rates
CVSHealth insurer stocks are trading higher after the market close on Monday following a report indicating the Trump administration will increase payment rates for Medicare insurers.
A Closer Look at CVS Health's Options Market Dynamics
CVSSPX Nosedives 4.5%: Can ETFs Like SPY Weather The Market Storm?
CVSSPX-USD lost over 4.5% in Q1 of 2025 due to economic uncertainty and trade war fears. Investor sentiment remains in Extreme Fear category.
Is CVS Health Gaining or Losing Market Support?
CVSDeep Dive Into CVS Health Stock: Analyst Perspectives (8 Ratings)
CVS